Brand Engagement Network (BNAI) 10-Q 15 Aug 22 2022 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2022	Aug. 12, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2022
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity Registrant Name	DHC Acquisition Corp.
Entity Central Index Key	0001838163
Entity File Number	001-40130
Entity Tax Identification Number	98-1574798
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	E9
Entity Shell Company	true
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, Address Line One	535 Silicon Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Southlake
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	76092
City Area Code	214
Local Phone Number	452-2300
Common Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	DHCA
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		30,945,072
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,736,268
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A ordinary shares, $0.0001 par value, and one-third of one redeemable warrant
Trading Symbol	DHCAU
Security Exchange Name	NASDAQ
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
Trading Symbol	DHCAW
Security Exchange Name	NASDAQ

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 405,645	$ 861,474
Due from Sponsor	1,500
Prepaid expenses	269,202	388,666
Total Current Assets	676,347	1,250,140
Investment held in Trust Account	309,898,791	309,450,720
TOTAL ASSETS	310,575,138	310,700,860
Current liabilities
Accounts payable and accrued expenses	2,397,170	1,024,627
Total Current Liabilities	2,397,170	1,024,627
Warrant liabilities	1,201,839	8,299,434
Deferred underwriting fee payable	10,830,775	10,830,775
Total Liabilities	14,429,784	20,154,836
Commitments and Contingencies
Class A ordinary shares subject to possible redemption; 30,945,072 shares at a redemption value of $10.01 and $10.00 per share at June 30, 2022 and December 31, 2021, respectively	309,898,791	309,450,720
Shareholders' Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding
Additional paid-in capital	0	0
Accumulated deficit	(13,754,211)	(18,905,470)
Total Shareholders' Deficit	(13,753,437)	(18,904,696)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT	310,575,138	310,700,860
Class A ordinary shares
Current liabilities
Class A ordinary shares subject to possible redemption; 30,945,072 shares at a redemption value of $10.01 and $10.00 per share at June 30, 2022 and December 31, 2021, respectively	309,898,791	309,450,720
Shareholders' Deficit
Common stock value	0	0
Class B ordinary shares
Shareholders' Deficit
Common stock value	$ 774	$ 774

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common stock par value	$ 10
Class A ordinary shares
Ordinary shares subject to possible redemption	30,945,072	30,945,072
Ordinary shares subject to possible redemption par value	$ 10.01	$ 10
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	500,000,000	500,000,000
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Class B ordinary shares
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	50,000,000	50,000,000
Common stock shares issued	7,736,268	7,736,268
Common stock shares outstanding	7,736,268	7,736,268

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating and formation costs	$ 243,574	$ 752,597	$ 1,946,336	$ 912,613
Loss from operations	(243,574)	(752,597)	(1,946,336)	(912,613)
Other income (expense):
Change in fair value of warrant liabilities	2,594,396	103,151	7,097,595	(554,490)
Transaction costs allocable to warrant liabilities	0	0	0	(586,339)
Interest earned on investments held in the Trust Account	417,862	0	448,071	0
Other income (expense), net	3,012,258	103,151	7,545,666	(1,140,829)
Net income (loss)	$ 2,768,684	(649,446)	5,599,330	(2,053,442)
Common Class A [Member]
Other income (expense):
Net income (loss)		$ (519,557)	$ 4,479,464	$ (1,488,651)
Basic weighted average shares outstanding	30,945,072	30,945,072	30,945,072	20,174,135
Basic net income (loss) per share	$ 0.07	$ (0.02)	$ 0.14	$ (0.07)
Diluted weighted average shares outstanding	30,945,072	30,945,072	30,945,072	20,174,135
Diluted net income (loss) per share	$ 0.07	$ (0.02)	$ 0.14	$ (0.07)
Common Class B [Member]
Other income (expense):
Net income (loss)	$ 553,737	$ (129,889)	$ 1,119,866	$ (564,791)
Basic weighted average shares outstanding	7,736,268	7,736,268	7,736,268	7,654,031
Basic net income (loss) per share	$ 0.07	$ (0.02)	$ 0.14	$ (0.07)
Diluted weighted average shares outstanding	7,736,268	7,736,268	7,736,268	7,654,031
Diluted net income (loss) per share	$ 0.07	$ (0.02)	$ 0.14	$ (0.07)

Condensed Statements of Changes

Condensed Statements of Changes in Shareholders' Equity (Deficit) - USD ($)	Total	Class B ordinary shares	Common Stock [Member] Class B ordinary shares	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2020	$ 20,000		$ 863	$ 24,137	$ (5,000)
Beginning balance, shares at Dec. 31, 2020			8,625,000
Cash paid in excess of fair value for private warrants	3,133,522			3,133,522
Forfeiture of Founder Shares			$ (89)	89
Forfeiture of Founder Shares, Shares			(888,732)
Accretion for Class A ordinary shares to redemption amount	(27,136,138)			(3,157,748)	(23,978,390)
Net income (loss)	(1,403,996)				(1,403,996)
Ending balance at Mar. 31, 2021	(25,386,612)		$ 774		(25,387,386)
Ending balance, shares at Mar. 31, 2021			7,736,268
Beginning balance at Dec. 31, 2020	20,000		$ 863	24,137	(5,000)
Beginning balance, shares at Dec. 31, 2020			8,625,000
Forfeiture of Founder Shares	89
Net income (loss)	(2,053,442)	$ (564,791)
Ending balance at Jun. 30, 2021	(26,036,058)		$ 774		(26,036,832)
Ending balance, shares at Jun. 30, 2021			7,736,268
Beginning balance at Dec. 31, 2020	20,000		$ 863	24,137	(5,000)
Beginning balance, shares at Dec. 31, 2020			8,625,000
Ending balance at Dec. 31, 2021	(18,904,696)		$ 774	0	(18,905,470)
Ending balance, shares at Dec. 31, 2021			7,736,268
Beginning balance at Mar. 31, 2021	(25,386,612)		$ 774		(25,387,386)
Beginning balance, shares at Mar. 31, 2021			7,736,268
Net income (loss)	(649,446)	(129,889)			(649,446)
Ending balance at Jun. 30, 2021	(26,036,058)		$ 774		(26,036,832)
Ending balance, shares at Jun. 30, 2021			7,736,268
Beginning balance at Dec. 31, 2021	(18,904,696)		$ 774	0	(18,905,470)
Beginning balance, shares at Dec. 31, 2021			7,736,268
Net income (loss)	2,830,646				2,830,646
Ending balance at Mar. 31, 2022	(16,074,050)		$ 774		(16,074,824)
Ending balance, shares at Mar. 31, 2022			7,736,268
Beginning balance at Dec. 31, 2021	(18,904,696)		$ 774	0	(18,905,470)
Beginning balance, shares at Dec. 31, 2021			7,736,268
Forfeiture of Founder Shares	0
Net income (loss)	5,599,330	1,119,866
Ending balance at Jun. 30, 2022	(13,753,437)		$ 774		(13,754,211)
Ending balance, shares at Jun. 30, 2022			7,736,268
Beginning balance at Mar. 31, 2022	(16,074,050)		$ 774		(16,074,824)
Beginning balance, shares at Mar. 31, 2022			7,736,268
Accretion for Class A ordinary shares to redemption amount	(448,071)			0	(448,071)
Net income (loss)	2,768,684	$ 553,737			2,768,684
Ending balance at Jun. 30, 2022	$ (13,753,437)		$ 774		$ (13,754,211)
Ending balance, shares at Jun. 30, 2022			7,736,268

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)			$ 5,599,330	$ (2,053,442)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on investments held in the Trust Account	$ (417,862)	$ 0	(448,071)	0
Change in fair value of warrant liabilities	(2,594,396)	(103,151)	(7,097,595)	554,490
Transaction costs allocated to warrant liabilities	0	0	0	586,339
Changes in operating assets and liabilities:
Due from Sponsor			(1,500)
Prepaid expenses			119,464	(718,111)
Accounts payable and accrued expenses			1,372,543	59,405
Net cash used in operating activities			(455,829)	(1,571,319)
Cash Flows from Investing Activities:
Investment of cash in Trust Account			0	(309,450,720)
Net cash used in investing activities			0	(309,450,720)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid			0	303,261,706
Proceeds from sale of Private Placement Warrants			0	9,189,015
Advances from related party			0	123,780
Repayment of promissory note – related party			0	(171,357)
Payment of offering costs			0	(300,000)
Net cash provided by financing activities			0	312,103,144
Net Change in Cash			(455,829)	1,081,105
Cash – Beginning of period			861,474	0	$ 0
Cash – End of period	$ 405,645	$ 1,081,105	405,645	1,081,105	$ 861,474
Non-cash investing and financing activities:
Offering costs included in accrued offering costs			0	17,000
Offering costs paid through promissory note			0	130,916
Payment of prepaid expenses through promissory note			0	26,800
Deferred underwriting fee payable			0	10,830,775
Forfeiture of Founder Shares			$ 0	$ (89)

Description of Organization and

Description of Organization and Business Operations	6 Months Ended
	Jun. 30, 2022
Business Description And Basis Of Presentation [Abstract]
Description of Organization and Business Operations	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS DHC Acquisition Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on December 22, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. All activity through June 30, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination and activities in connection with the Proposed Business Combination (as defined and discussed below). The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating The registration statement for the Company’s Initial Public Offering was declared effective on March 1, 2021. On March 4, 2021, the Company consummated the Initial Public Offering of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 6,000,000 warrants (the “Private Placement Warrants”) at a price o f per Private Placement Warrant in a private placement to the Sponsor generating gross proceeds Following the closing of the Initial Public Offering on March 4, 2021, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”), located in the United States and will be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or les 2a-7 of On March 5, 2021, the underwriters partially exercised their over-allotment option, resulting in an additional 945,072 Units issued for an aggregate amount of $9,450,720. In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 126,010 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $189,015. A total of $9,450,720 was deposited into the Trust Account, bringing the aggregate proceeds deposited in the Trust Account to $309,450,720. Transaction costs amounted to $17,501,346, consisting of $6,189,014 in cash underwriting fees, net of reimbursement, $10,830,775 of deferred underwriting fees and $481,557 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of the stock exchange that the Company will list its securities on will require that the Company’s initial Business Combination must be with one or more target businesses that have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the signing of a definitive agreement in connection with the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide the holders of its issued and outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the Business Combination, (initially $ per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and net of taxes payable), divided by the number of then issued and outstanding Public Shares. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote any Founder Shares (as defined in Note 5) and Public Shares held by it in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against an Initial Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors have agreed to waive: (i) their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of the Company’s Business Combination and (ii) their redemption rights with respect to the Founder Shares and any Public Shares held by them in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering or (B) with respect to any other provision relating to shareholders’ rights and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to consummate an initial business combination within 24 months from the closing of the Company’s Initial Public Offering. The Company has until March 4, 2023 to complete a Business Combination (the “Combination Period”). If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten per-share The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below (i) $10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Proposed Business Combination On July 25, 2022, Company entered into a Business Combination Agreement and Plan of Reorganization (the “Business Combination Agreement”), by and among the Company, Glory Merger Subsidiary Corp., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”) and With Purpose, Inc. (d/b/a GloriFi, Inc.) a Delaware corporation (“GloriFi”). The Business Combination Agreement provides that, among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the other agreements and transactions contemplated by the Business Combination Agreement, the “Proposed Business Combination”): (i) prior to (but no later than the day preceding) the date of the closing of the Proposed Business Combination, the Company shall migrate to and domesticate as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended (“DGCL”) and the Companies Act (as revised) of the Cayman Islands (the “Domestication”), upon which each share of Class A ordinary shares, $0.0001 par value per share, of the Company (“Company Class A Ordinary Shares”) shall be converted into one share of Class A common stock, $0.0001 par value per share of the Company (“Company Class A Common Stock”), and each share of Class B ordinary shares, $0.0001 par value per share, of the Company (“Company Class B Ordinary Shares”) shall be converted into one share of Class B common stock, $0.0001 par value per share, of the Company (the “Founders Class B Common Stock”) and together with the Company Class A Common Stock, the “Company Common Stock”); (ii) immediately prior to the closing of the Proposed Business Combination and following the Domestication, each share of Founders Class B Common Stock shall automatically convert into one share of Company Class A Common Stock; (iii) at the closing of the Proposed Business Combination (the “Closing”) and following the Domestication, upon the terms and subject to the conditions of the Business Combination Agreement and in accordance with the DGCL, Merger Sub will merge with and into GloriFi, the separate corporate existence of Merger Sub shall cease and GloriFi shall continue as the surviving corporation of the merger and a wholly owned subsidiary of the Company (the “Merger”); (iv) as a result of the Merger, among other things, (a) all outstanding shares of Class A Common Stock of GloriFi held by any GloriFi current stockholder will be converted into the right to receive (1) a number of shares of Company Class A Common Stock equal to (x) the exchange ratio multiplied by (y) the number of shares of Class A Common Stock of GloriFi held by any GloriFi stockholder as of immediately prior to the effective time of the Merger (the “Effective Time”) and (2) its pro rata portion of up to 40 million shares of Company Class A Common Stock (as may be increased as a result of the forfeiture following the Closing of exchanged GloriFi restricted stock and restricted stock units) upon the closing price of the Company Class A Common Stock exceeding certain price thresholds for any 20 out of 30 consecutive trading day period in the seven year period following the Closing (the “Earnout Shares”) and (b) all outstanding shares of Class B Common Stock of GloriFi held by any GloriFi stockholder will be converted into the right to receive (1) a number of shares of Company Common Stock equal to (x) the exchange ratio multiplied by (y) the number of shares of Class B Common Stock of GloriFi held by such stockholder as of immediately prior to the Effective Time and (2) its pro rata portion of the Earnout Shares, in each case of clauses (a) and (b), other than treasury shares and dissenting shares; and (v) the Company will be renamed “GloriFi, Inc.” or such other name as mutually agreed by the Company and GloriFi. The transaction has been unanimously approved by the Company’s and GloriFi’s Board of Directors and is subject to the satisfaction or waiver of certain customary closing conditions, including, among others, (i) approval of the Proposed Business Combination and related agreements and transactions by the respective shareholders of the Company and GloriFi, (ii) effectiveness of the registration statement on Form S-4 to be filed by the Company in connection with the Proposed Business Combination; (iii) the absence of laws or governmental orders prohibiting the Proposed Business Combination, (iv) expiration or termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, (v) the Company having at least $5,000,0001 of net tangible assets upon the Closing, (vi) the completion of the Domestication, (vii) customary bringdown of the representations, warranties and covenants of the parties, (viii) the receipt of certain required regulatory approvals, (ix) the consummation of one or more financing transactions by GloriFi resulting in GloriFi’s receipt of unencumbered cash proceeds of at least $60,000,000, (x) the completion of a bank acquisition by an affiliate of GloriFi and the entry into a Marketing Program Framework Agreement by GloriFi with such affiliate or GloriFi having entered into an agreement with one or more state, or federally, charted financial institutions in a form reasonably acceptable to the Company, (xi) receipt of approval for listing on the Nasdaq Stock Market LLC of the shares of Company Common Stock to be issued in connection with the Merger, and (xii) the Company having made all appropriate and necessary arrangements with the trustee of its Trust Fund (as defined below) to have all remaining funds released to the Company. Another condition to GloriFi’s obligation to consummate the Merger is that, as of the Closing, the amount of cash (i) available in the trust account into which substantially all of the proceeds of the Company’s initial public offering have been deposited for the benefit of the Company, certain of its public shareholders and the underwriters of the Company’s initial public offering (the “Trust Fund”), after deducting the amount required to satisfy the Company’s obligations to its shareholders (if any) that exercise their rights to redeem all or a portion of their Company Class A Ordinary Shares, in accordance with the Company’s articles of association currently in effect, plus (ii) all cash proceeds received by the Company at, prior to or immediately after the Effective Time from the issuance of Company Class A Ordinary Shares, Company Class A Common Stock or Company units at a purchase price of not less than $10.00 per share or per unit, or otherwise in connection with any backstop financing, plus (iii) the aggregate commitment amounts pursuant to any equity financing facility entered into by the Company at or prior to the Closing, provided that the form of such equity financing facility is reasonably acceptable to GloriFi, shall be equal to or greater than $30,000,000. The Business Combination Agreement contains additional covenants, including, among others, providing for (i) the parties to conduct their respective businesses in the ordinary course through the Closing, subject to certain exceptions, (ii) the parties to not initiate any negotiations or enter into any agreements for certain alternative transactions, (iii) GloriFi to prepare and the Company to file a registration statement on Form S-4, which shall include a proxy statement / consent solicitation statement, and take certain other actions to obtain the requisite approval of the Company’s shareholders of certain proposals regarding the Proposed Business Combination, (iv) the parties to use reasonable best efforts to obtain necessary approvals from government agencies and (v) GloriFi using reasonable best efforts to consummate financing transactions prior to September 30, 2022 resulting in the receipt of at least $60,000,000 in unencumbered cash proceeds by GloriFi. The consummation of the Proposed Business Combination is subject to certain conditions as further described in the Business Combination Agreement. Liquidity and Going Concern The accompanying condensed financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As of June 30, 2022, the Company had $405,645 in its operating bank account and a working capital deficit of $1,720,823. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of June 30, 2022, there were no amounts outstanding under any Working Capital Loan. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15,

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed condensed Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three Investment Held in Trust Account At June 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury Securities. At December 31, 2021, substantially all of the assets held in the Trust Account were held in a checking account held by Continental Stock Transfer & Trust Company. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Company coverage of $250,000. The Company has not experienced losses on these accounts. Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as incurred in the condensed statements of operations. Offering costs associated with the Class A ordinary shares issued were initially charged to temporary equity and then accreted to the redemption value of the Class A ordinary shares subject to redemption upon the completion of the Initial Public Offering. Offering costs amounted to $17,501,346, of which $16,915,008 was charged to temporary shareholders’ deficit upon the completion of the Initial Public Offering and $586,339 was expensed to the condensed statements of operations. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption, if any, are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2022 and December 31, 2021, 30,945,072 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in At June 30, 2022 and December 31, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 309,450,720 Less: Proceeds allocated to Public Warrants (10,211,874 ) Class A ordinary shares issuance costs (16,924,264 ) Plus: Accretion of carrying value to redemption value 27,136,138 Class A ordinary shares subject to possible redemption as of December 31, 2021 $ 309,450,720 Plus: Accretion of carrying value to redemption value 448,071 Class A ordinary shares subject to possible redemption as of June 30, 2022 $ 309,898,791 Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share 815-40 re-measurement Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2022 and December 31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 16,441,034 shares of Class A ordinary share in the aggregate. As of June 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended Three Months Ended June 30, 2021 Six Months Ended Six Months Ended Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss), as adjusted $ 2,214,947 $ 553,737 $ (519,557 ) (129,889 ) $ 4,479,464 $ 1,119,866 $ (1,488,651 ) $ (564,791 ) Denominator: Basic and diluted weighted average shares outstanding 30,945,072 7,736,268 30,945,072 7,736,268 30,945,072 7,736,268 20,174,135 7,654,031 Basic and diluted net income (loss) per ordinary share $ 0.07 $ 0.07 $ (0.02 ) (0.02 ) $ 0.14 $ 0.14 $ (0.07 ) $ (0.07 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the warrant liabilities (see Note 9). Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic470-20) 815-40)” 2020-06”), 2020-06 if-converted 2020-06 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Public Offering

Public Offering	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Public Offering	NOTE 3. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 30,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-third In connection with the underwriters’ partial exercise of their over-allotment option, the Company also consummated the sale of an additional 126,010 Private Placement Warrants at $1.50 per Private Placement Warrant, generating total proceeds of $189,015. A total of $9,450,720 was deposited into the Trust Account, bringing the aggregate proceeds deposited in the Trust Account to $309,450,720.

Private Placement

Private Placement	6 Months Ended
	Jun. 30, 2022
Private Placement [Abstract]
Private Placement	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 6,000,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $9,000,000. The Sponsor agreed to purchase up to an additional 600,000 Private Placement Warrants, for an aggregate purchase price of an additional $900,000, if the over-allotment option is exercised in part by the underwriters. On March 5, the Sponsor purchased 126,010 Private Placement Warrants for an additional aggregate purchase price of $189,015 in connection with the partial exercise of the underwriter’s over-allotment option. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9). A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In December 2020, the Sponsor paid $25,000 to cover certain expenses on behalf of the Company in consideration for 7,187,500 Class B ordinary shares (the “Founder Shares”). On March 1, 2021, the Company effected a share capitalization, pursuant to which an additional 1,437,500 Class B ordinary shares were issued, resulting in an aggregate of 8,625,000 Founder Shares outstanding. Historical information has been retroactively restated. The Founder Shares included an aggregate of up to 1,125,000 shares that were subject to forfeiture by the Sponsor following to the extent the underwriters’ election to exercise their over-allotment option was not exercised so that the number of Founder Shares collectively represented 20% of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). As a result of the underwriters’ not exercising their overallotment option in full, 888,732 Founder Shares were forfeited on April 15, 2021. The Sponsor has agreed, not to transfer, assign or sell any Founder Shares until the earlier to occur of (i) one year after the completion of the Company’s Business Combination and (ii) subsequent to a Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day In connection with the entering into the Business Combination Agreement, on July 25, 2022, the Company will enter into into a Sponsor Agreement (the “Sponsor Agreement”), by and among the Sponsor, LLC, GloriFi, the Company and the directors of Company, pursuant to which the Sponsor agreed to, among other things, vote in favor of the Business Combination Agreement and the Proposed Business Combination and not to transfer any Company securities held by the Sponsor prior to the Closing, subject to certain exceptions, in each case, subject to the terms and conditions contemplated by the Sponsor Agreement, and the term of the lock-up to which the founder shares held by the Sponsor and directors of the Company are subject after the Closing was amended to be the earlier of (i) 180 days following the Closing or (ii) the date on which the closing price of Company Class A Common Stock equals or exceeds $12.50 per share for any 20 out of 30 consecutive trading days. The Sponsor Agreement amended and restated in its entirety Section 5(a) of the Letter Agreement, dated March 4, 2021, by among the Company, Sponsor and the Company’s directors, which contained, among other things, the lock-up period applicable to the Sponsor. Administrative Services Agreement The . , respectively. As of June 30, 2022 and December 31, 2021, the company had $160,000 and $100,000 included in accounts payable and accrued expense on the accompanying condensed balance sheet, respectively. Promissory Note — Related Party On December 29, 2020, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. Such warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of June 30, 2022 and December 31, 2021, there were no working capital loans outstanding.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or the completion of the Proposed Business Combination, the specific impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Various social and political circumstances in the United States and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the rising conflict between Russia and Ukraine, and resulting market volatility could adversely affect the Company’s ability to complete a business combination. In response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a business combination and the value of the Company’s securities. Registration Rights Pursuance to a registration rights agreement entered into on March 4, 2021, the holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provide that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period, which occurs (i) in the case of the Founder Shares, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. In connection with the Proposed Business Combination, the registration rights agreement will be amended and restated. Underwriting Agreement The Company granted the underwriters a 45-day The underwriters are entitled to a deferred fee of $ per Unit, or $ in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Consulting Agreement On January 27, 2021, the Company entered into a Consulting Agreement for financial advisory services. The Company agrees to pay the consultant $2,000,000 and reimburse the consultant for all reasonable and documented expenses, which shall be earned upon announcement of an initial Business Combination and payable at the closing of the initial Business Combination. On July 25, 2022, the company announced its initial Business Combination target. Business Combination Agreement On July 25, 2022, the Company entered into a Business Combination Agreement and Plan of Reorganization (the “Business Combination Agreement”), by and among the Company, Glory Merger Subsidiary Corp., a Delaware corporation and a direct wholly owned subsidiary of DHC (“Merger Sub”) and With Purpose, Inc. (d/b/a GloriFi, Inc.) a Delaware corporation (“GloriFi”). The Merger The Business Combination Agreement provides that, among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the other agreements and transactions contemplated by the Business Combination Agreement, the “Business Combination”): (i) prior to (but no later than the day preceding) the date of the closing of the Business Combination, the Company shall migrate to and domesticate as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended (“DGCL”) and the Companies Act (as revised) of the Cayman Islands (the “Domestication”), upon which each share of Class A ordinary shares, $0.0001 par value per share, of the Company (“DHC Class A Ordinary Shares”) shall be converted into one share of Class A common stock, $0.0001 par value per share of the Company (“DHC Class A Common Stock”), and each share of Class B ordinary shares, $0.0001 par value per share, of the Company (“DHC Class B Ordinary Shares”) shall be converted into one share of Class B common stock, $0.0001 par value per share, of the Company (the “Founders Class B Common Stock”) and together with DHC Class A Common Stock, “DHC Common Stock”); (ii) immediately prior to the closing of the Business Combination and following the Domestication, each share of Founders Class B Common Stock shall automatically convert into one share of DHC Class A Common Stock; (iii) at the closing of the Business Combination (the “Closing”) and following the Domestication, upon the terms and subject to the conditions of the Business Combination Agreement and in accordance with the DGCL, Merger Sub will merge with and into GloriFi, the separate corporate (iv) as a result of the Merger, among other things, (a) all outstanding shares of Class A Common Stock of GloriFi held by any GloriFi current stockholder will be converted into the right to receive (1) a number of shares of DHC Class A Common Stock equal to (x) the exchange ratio multiplied by (y) the number of shares of Class A Common Stock of GloriFi held by any GloriFi stockholder as of immediately prior to the effective time of the Merger (the “Effective Time”) and (2) its pro rata portion of up to 40 million shares of DHC Class A Common Stock (as may be increased as a result of the forfeiture following the Closing of exchanged GloriFi restricted stock and restricted stock units) upon the closing price of the DHC Class A Common Stock exceeding certain price thresholds for any 20 out of 30 consecutive trading day period in the seven year period following the Closing (the “Earnout Shares”) (iv) the Company will be renamed “GloriFi, Inc.” or such other name as mutually agreed by the Company and GloriFi. The Board of Directors of the Company has (i) determined that it is advisable to enter into the Business Combination Agreement and the documents contemplated thereby, (ii) approved the execution and delivery of the Business Combination Agreement and the documents contemplated thereby and the transactions contemplated thereby, and (iii) recommended the adoption and approval of the Business Combination Agreement and the other documents contemplated thereby and the transactions contemplated thereby by its shareholders. Sponsor Support Agreement On July 25, 2022, the Company entered into a Sponsor Agreement (the “Sponsor Agreement”), by and among DHC Sponsor, LLC (the “Sponsor”), GloriFi, the Company and the directors of the Company, pursuant to which the Sponsor agreed to, among other things, vote in favor of the Business Combination Agreement and the Business Combination and not to transfer any the Company securities held by the Sponsor prior to the Closing, subject to certain exceptions, in each case, subject to the terms and conditions contemplated by the Sponsor Agreement, and the term of the lock-up to which the founder shares held by the Sponsor and directors of the Company are subject after the Closing was amended to be the earlier of (i) 180 days following the Closing or (ii) the date on which the closing price of DHC Class A Common Stock equals or exceeds $12.50 per share for any 20 out of 30 consecutive trading days. Stockholder Support Agreements On July 25, 2022, the Company entered into Stockholder Support Agreements (the “Stockholder Support Agreements”), by and among the Company, GloriFi and certain stockholders of GloriFi (the “Key Stockholders”). Pursuant to the Stockholder Support Agreements, the Key Stockholders agreed to, among other things, execute and deliver a written consent with respect to the outstanding shares of GloriFi capital stock held by the Key Stockholders adopting the Business Combination Agreement and related transactions and approving the Business Combination, and not transfer any shares of GloriFi capital stock held by them prior to the Closing, subject to certain exceptions. Such written consent must be delivered promptly, and in any event within forty-eight (48) hours after the Registration Statement on Form S-4 is declared effective by the SEC. The shares of GloriFi capital stock that are owned by the Key Stockholders and subject to the Stockholder Support Agreements represent at least two-thirds of the outstanding voting power of GloriFi capital stock.

Shareholders' Deficit

Shareholders' Deficit	6 Months Ended
	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Shareholders' Deficit	NOTE 7. SHAREHOLDERS’ DEFICIT Preference Shares — Class A Ordinary Shares Class B Ordinary Shares Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law; provided that only holders of Class B ordinary shares have the right to vote on the appointment of directors prior to the Company’s initial Business Combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination on a one-for-one

Warrants Liabilities

Warrants Liabilities	6 Months Ended
	Jun. 30, 2022
Warrants Liabilities [Abstract]
Warrants Liabilities	NOTE 8. WARRANT LIABILITIES As of June 30, 2022 and December 31, 2021, there were 10,315,024 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) one year from the closing of the Initial Public Offering and (b) 30 days after the completion of a Business Combination. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. The Company has agreed that as soon as practicable, but in no event later than twenty Once the warrants become exercisable, the Company may redeem the Public Warrants for redemption (Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading The Company will not redeem the warrants unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00. • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day In addition, if (x) the Company issue additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the trading day period starting on the trading day prior to the day on which the Company consummates its initial business combination (such price, the “Market Value”) is below $ per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to % of the higher of the Market Value and the Newly Issued Price, the $ per share redemption trigger price will be adjusted (to the nearest cent) to be equal to % of the higher of the Market Value and the Newly Issued Price, and the $ per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. As of June 30, 2022 and December 31, 2021, there were 6,126,010 Private Placement Warrants outstanding. The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that (x) the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 9. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on an assessment of the assumptions that market participants would use in pricing the asset or liability. At June 30, 2022, assets held in the Trust Account were comprised of $309,898,791 of money market funds which are invested primarily in U.S. Treasury Securities. During the three and six months ended June 30, 2022, the Company did no At December 31, 2021, assets held in the Trust Account were comprised of $309,450,720 in a checking account held by Continental Stock Transfer and Trust Company. During the year ended December 31, 2021, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at June 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: June 30, 2022 December 31, 2021 Level Amount Level Amount Assets: 1 $ 309,898,790.83 — — Investment held in Trust Account Liabilities: Warrant Liabilities – Public Warrants 1 $ 754,028 1 $ 5,207,024 Warrant Liabilities – Private Placement Warrants 2 $ 447,811 2 $ 3,092,410 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Company’s accompanying June 30, 2022 and December 31, 2021 condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations. The Company established the initial fair value for the Warrants on March 4, 2021, the date of the Company’s Initial Public Offering, using a Monte Carlo Simulation for the Private Placement Warrants and the Public Warrants. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units is classified as Level 1 due to the use of an observable market quote in an active market under the ticker DHCAW. The subsequent measurements of the Private Placement Warrants are classified as Level 2 due to the use of the closing price of the Public Warrants, an observable market quote for a similar asset in an active market. For June 30, 2022 and December 31, 2021, the Public Warrants have detached from the Units, and the closing price is utilized as the fair value. The following table presents the changes in the fair value of Level 3 warrant liabilities for the three and six months ended June 30, 2021: Private Placement Public Warrant Liabilities Fair value as of January 1, 2021 $ — $ — $ — Initial measurement on March 4, 2021 (IPO) 5,940,000 9,900,000 15,840,000 Initial measurement on March 5, 2021 (Over allotment) 124,750 311,874 436,624 Change in fair value 245,040 412,621 657,641 Fair value as of March 31, 2021 $ 6,309,790 $ 10,624,475 $ 16,934,265 Change in fair value — (103,151 ) (103,151 ) Transfer to Level 1 — (10,521,324 ) (10,521,324 ) Fair value as of June 30, 2021 $ 6,309,790 $ — $ 6,309,790 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement during the six months ended June 30, 2021 was $10,521,324. There were no transfers from Level 3 to Level 2 during the three and six months ended June 30, 2021.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 10. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the condensed financial statements were available to be issued. Based upon this review, other than the below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements. Business Combination Agreement On July 25, 2022, the Company entered into the Business Combination Agreement. In connection with entering into the Business Combination Agreement, the Company has entered into an agreement with its legal counsel, (“Counsel”), whereby the if the Business Combination Agreement is terminated pursuant to Section 9.01, the Company shall promptly pay to Counsel no less than $500,000 no later than two business days after the date on which the Business Combination Agreement is terminated. The payment of the $500,000 does not constitute a waiver of any other fees and expenses that are due to Counsel from the Company in accounts receivable and work-in-progress. The Merger The Business Combination Agreement provides that, among other things and upon the terms and subject to the conditions thereof, the following transactions will occur (together with the other agreements and transactions contemplated by the Business Combination Agreement, the “Business Combination”): (i) prior to (but no later than the day preceding) the date of the closing of the Business Combination, the Company shall migrate to and domesticate as a Delaware corporation in accordance with Section 388 of the Delaware General Corporation Law, as amended (“DGCL”) and the Companies Act (as revised) of the Cayman Islands (the “Domestication”), upon which each share of Class A ordinary shares, $0.0001 par value per share, of the Company (“DHC Class A Ordinary Shares”) shall be converted into one share of Class A common stock, $0.0001 par value per share of the Company (“DHC Class A Common Stock”), and each share of Class B ordinary shares, $0.0001 par value per share, of the Company (“DHC Class B Ordinary Shares”) shall be converted into one share of Class B common stock, $0.0001 par value per share, of the Company (the “Founders Class B Common Stock”) and together with DHC Class A Common Stock, “DHC Common Stock”); (ii) immediately prior to the closing of the Business Combination and following the Domestication, each share of Founders Class B Common Stock shall automatically convert into one share of DHC Class A Common Stock; (iii) at the closing of the Business Combination (the “Closing”) and following the Domestication, upon the terms and subject to the conditions of the Business Combination Agreement and in accordance with the DGCL, Merger Sub will merge with and into GloriFi, the separate corporate (iv) as a result of the Merger, among other things, (a) all outstanding shares of Class A Common Stock of GloriFi held by any GloriFi current stockholder will be converted into the right to receive (1) a number of shares of DHC Class A Common Stock equal to (x) the exchange ratio multiplied by (y) the number of shares of Class A Common Stock of GloriFi held by any GloriFi stockholder as of immediately prior to the effective time of the Merger (the “Effective Time”) and (2) its pro rata portion of up to 40 million shares of DHC Class A Common Stock (as may be increased as a result of the forfeiture following the Closing of exchanged GloriFi restricted stock and restricted stock units) upon the closing price of the DHC Class A Common Stock exceeding certain price thresholds for any 20 out of 30 consecutive trading day period in the seven year period following the Closing (the “Earnout Shares”) (iv) the Company will be renamed “GloriFi, Inc.” or such other name as mutually agreed by the Company and GloriFi. The Board of Directors of the Company has (i) determined that it is advisable to enter into the Business Combination Agreement and the documents contemplated thereby, (ii) approved the execution and delivery of the Business Combination Agreement and the documents contemplated thereby and the transactions contemplated thereby, and (iii) recommended the adoption and approval of the Business Combination Agreement and the other documents contemplated thereby and the transactions contemplated thereby by its shareholders. Sponsor Support Agreement On July 25, 2022, the Company entered into a Sponsor Agreement (the “Sponsor Agreement”), by and among DHC Sponsor, LLC (the “Sponsor”), GloriFi, the Company and the directors of the Company, pursuant to which the Sponsor agreed to, among other things, vote in favor of the Business Combination Agreement and the Business Combination and not to transfer any the Company securities held by the Sponsor prior to the Closing, subject to certain exceptions, in each case, subject to the terms and conditions contemplated by the Sponsor Agreement, and the term of the lock-up to which the founder shares held by the Sponsor and directors of the Company are subject after the Closing was amended to be the earlier of (i) 180 days following the Closing or (ii) the date on which the closing price of DHC Class A Common Stock equals or exceeds $12.50 per share for any 20 out of 30 consecutive trading days. Stockholder Support Agreements On July 25, 2022, the Company entered into Stockholder Support Agreements (the “Stockholder Support Agreements”), by and among the Company, GloriFi and certain stockholders of GloriFi (the “Key Stockholders”). Pursuant to the Stockholder Support Agreements, the Key Stockholders agreed to, among other things, execute and deliver a written consent with respect to the outstanding shares of GloriFi capital stock held by the Key Stockholders adopting the Business Combination Agreement and related transactions and approving the Business Combination, and not transfer any shares of GloriFi capital stock held by them prior to the Closing, subject to certain exceptions. Such written consent must be delivered promptly, and in any event within forty-eight (48) hours after the Registration Statement on Form S-4 is declared effective by the SEC. The shares of GloriFi capital stock that are owned by the Key Stockholders and subject to the Stockholder Support Agreements represent at least two-thirds of the outstanding voting power of GloriFi capital stock. In connection with the consulting agreement, as disclosed in Note 6, and the announcement of the initial Business Combination target on July 25, 2022, the company incurred the $2,000,000 fee, which is payable upon the closing of the Business Combination.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed condensed
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three
Investment Held in Trust Account	Investment Held in Trust Account At June 30, 2022, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S. Treasury Securities. At December 31, 2021, substantially all of the assets held in the Trust Account were held in a checking account held by Continental Stock Transfer & Trust Company.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Company coverage of $250,000. The Company has not experienced losses on these accounts.
Offering Costs	Offering Costs Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as incurred in the condensed statements of operations. Offering costs associated with the Class A ordinary shares issued were initially charged to temporary equity and then accreted to the redemption value of the Class A ordinary shares subject to redemption upon the completion of the Initial Public Offering. Offering costs amounted to $17,501,346, of which $16,915,008 was charged to temporary shareholders’ deficit upon the completion of the Initial Public Offering and $586,339 was expensed to the condensed statements of operations.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption, if any, are classified as a liability instrument and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2022 and December 31, 2021, 30,945,072 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets, respectively. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A ordinary shares resulted in charges against additional paid-in At June 30, 2022 and December 31, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 309,450,720 Less: Proceeds allocated to Public Warrants (10,211,874 ) Class A ordinary shares issuance costs (16,924,264 ) Plus: Accretion of carrying value to redemption value 27,136,138 Class A ordinary shares subject to possible redemption as of December 31, 2021 $ 309,450,720 Plus: Accretion of carrying value to redemption value 448,071 Class A ordinary shares subject to possible redemption as of June 30, 2022 $ 309,898,791
Warrant Liabilities	Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share 815-40 re-measurement
Income Taxes	Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2022 and December 31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 16,441,034 shares of Class A ordinary share in the aggregate. As of June 30, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended Three Months Ended June 30, 2021 Six Months Ended Six Months Ended Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss), as adjusted $ 2,214,947 $ 553,737 $ (519,557 ) (129,889 ) $ 4,479,464 $ 1,119,866 $ (1,488,651 ) $ (564,791 ) Denominator: Basic and diluted weighted average shares outstanding 30,945,072 7,736,268 30,945,072 7,736,268 30,945,072 7,736,268 20,174,135 7,654,031 Basic and diluted net income (loss) per ordinary share $ 0.07 $ 0.07 $ (0.02 ) (0.02 ) $ 0.14 $ 0.14 $ (0.07 ) $ (0.07 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts, and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature, except for the warrant liabilities (see Note 9).
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic470-20) 815-40)” 2020-06”), 2020-06 if-converted 2020-06 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Basic and Diluted Income (Loss) Per Ordinary Share	The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts): Three Months Ended Three Months Ended June 30, 2021 Six Months Ended Six Months Ended Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share Numerator: Allocation of net income (loss), as adjusted $ 2,214,947 $ 553,737 $ (519,557 ) (129,889 ) $ 4,479,464 $ 1,119,866 $ (1,488,651 ) $ (564,791 ) Denominator: Basic and diluted weighted average shares outstanding 30,945,072 7,736,268 30,945,072 7,736,268 30,945,072 7,736,268 20,174,135 7,654,031 Basic and diluted net income (loss) per ordinary share $ 0.07 $ 0.07 $ (0.02 ) (0.02 ) $ 0.14 $ 0.14 $ (0.07 ) $ (0.07 )
Summary of Class A Common Stock Subject to Redemption	At June 30, 2022 and December 31, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 309,450,720 Less: Proceeds allocated to Public Warrants (10,211,874 ) Class A ordinary shares issuance costs (16,924,264 ) Plus: Accretion of carrying value to redemption value 27,136,138 Class A ordinary shares subject to possible redemption as of December 31, 2021 $ 309,450,720 Plus: Accretion of carrying value to redemption value 448,071 Class A ordinary shares subject to possible redemption as of June 30, 2022 $ 309,898,791

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Summary Company's Liabilities that are Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis at June 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: June 30, 2022 December 31, 2021 Level Amount Level Amount Assets: 1 $ 309,898,790.83 — — Investment held in Trust Account Liabilities: Warrant Liabilities – Public Warrants 1 $ 754,028 1 $ 5,207,024 Warrant Liabilities – Private Placement Warrants 2 $ 447,811 2 $ 3,092,410
Summary of Change in the Fair Value of Warrant Liabilities	The following table presents the changes in the fair value of Level 3 warrant liabilities for the three and six months ended June 30, 2021: Private Placement Public Warrant Liabilities Fair value as of January 1, 2021 $ — $ — $ — Initial measurement on March 4, 2021 (IPO) 5,940,000 9,900,000 15,840,000 Initial measurement on March 5, 2021 (Over allotment) 124,750 311,874 436,624 Change in fair value 245,040 412,621 657,641 Fair value as of March 31, 2021 $ 6,309,790 $ 10,624,475 $ 16,934,265 Change in fair value — (103,151 ) (103,151 ) Transfer to Level 1 — (10,521,324 ) (10,521,324 ) Fair value as of June 30, 2021 $ 6,309,790 $ — $ 6,309,790

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)				6 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 05, 2021	Mar. 04, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Company, incorporation date				Dec. 22, 2020
Stock issued during period, value			$ 300,000,000
Proceeds from issuance of warrants				$ 0	$ 9,189,015
Payment to acquire restricted investments				9,450,720
Assets held in the trust account				309,450,720
Transaction cost				17,501,346
Deferred underwriting fee payable				10,830,775
Other offering costs payable				$ 481,557
Percentage of asset held in trust account				80%
Number of days related to payment to acquire restricted investment				2 days
Net tangible assets required for consummation of business combination				$ 5,000,001
Number of months determining public shares redemption				24 months
Number of months related to consummation of business combination				24 months
Number of days for consummation of business combination				10 days
Dissolution expenses				$ 100,000
Cash underwriting fess Net of reimbursement			6,189,014
Cash				405,645		$ 861,474
Working Capital				$ 1,720,823
Common stock par value				$ 10
Minimum net worth required for compliance				$ 50,000,001
Minimum cash proceeds to be raised pursuant to equity financing one	$ 60,000,000			60,000,000
Minimum cash proceeds to be raised pursuant to equity financing				$ 30,000,000
Definitive Agreement of Initial Business Combination [Member]
Business combination, percentage of voting interest acquired				50%
Common Stock [Member]
Temporary equity redemption price per share				$ 10
Restricted percentage of redemption				15%
Percentage of redemption				100%
Share price				$ 10
Maximum [Member]
U.S. government securities, maturity terms				185 days
Number of trading days determining closing price of earnout shares				30 days
Minimum [Member]
U.S. government securities, maturity terms				0 days
Number of trading days determining closing price of earnout shares				20 days
Sponsor [Member]
Share price				$ 12
Sponsor [Member] | Working Capital Loan [Member]
Promissory note – related party				$ 0		$ 0
Common Class A [Member]
Common stock par value				$ 0.0001		$ 0.0001
Common stock shares issued				0		0
Common Class A [Member] | Private Placement Warrants [Member]
Share price				$ 18
Company Class B Ordinary Shares [Member]
Common stock par value				$ 0.0001
Common stock shares issued				40,000,000
Company Class A Common Stock [Member]
Common stock par value				$ 0.0001
Founders Class B Common Stock [Member]
Common stock par value				0.0001
IPO [Member]
Proceeds from issuance of warrants						$ 10,211,874
Share price				$ 10
IPO [Member] | Private Placement Warrants [Member] | Sponsor [Member]
Class of warrant or rights issued during period				6,000,000
Class of warrant or rights issued during period, price per warrant or right				$ 1.5
Proceeds from issuance of warrants				$ 9,000,000
Proceeds from sale of equity			$ 300,000,000
Proceeds from sale of equity, per unit			$ 10
IPO [Member] | Common Class A [Member]
Stock issued during period shares new issues			30,000,000
Shares issue price			$ 10
Stock issued during period			30,000,000
Over-Allotment Option [Member]
Stock issued during period shares new issues		945,072		4,500,000
Stock issued during period		945,072		4,500,000
Over-Allotment Option [Member] | Underwriters [Member] | Partial Exercise Of Over Allotment Option [Member]
Stock issued during period shares new issues		945,072
Stock issued during period, value		$ 9,450,720
Class of warrant or rights issued during period		126,010
Class of warrant or rights issued during period, price per warrant or right		$ 1.5
Proceeds from issuance of warrants		$ 189,015
Stock issued during period		945,072
Over-Allotment Option [Member] | Private Placement Warrants [Member] | Sponsor [Member]
Class of warrant or rights issued during period		126,010
Over-Allotment Option [Member] | Common Class A [Member]
Stock issued during period shares new issues		945,072	30,000,000
Shares issue price			$ 10
Stock issued during period, value		$ 9,450,720
Stock issued during period		945,072	30,000,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Future confirming events	one or more future confirming events
Cash equivalents, Carrying value	$ 0		$ 0
Unrecognized tax benefits	0		0
Unrecognized tax benefits, Amounts accrued for interest and penalties	0		$ 0
Income tax expenses benefit	0	$ 0
FDIC, Insured amount	$ 250,000
Weighted average number diluted shares outstanding adjustment	0	0
Class A ordinary shares
Temporary equity shares outstanding	30,945,072		30,945,072
Number of Common stock into which the class of warrant or right be converted	16,441,034
Maximum [Member]
Term of short term investments	9 months
Minimum [Member]
Term of short term investments	3 months

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Class A Common Stock Subject to Redemption (Detail) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Less:
Proceeds allocated to Public Warrants			$ 0	$ (9,189,015)
Plus:
Accretion of carrying value to redemption value	$ 448,071	$ 27,136,138
Class A Ordinary Shares Subject to Possible Redemption	309,898,791		309,898,791		$ 309,450,720
Common Class A [Member]
Less:
Class A ordinary shares issuance costs					(16,924,264)
Plus:
Accretion of carrying value to redemption value			448,071		27,136,138
Class A Ordinary Shares Subject to Possible Redemption	$ 309,898,791		$ 309,898,791		309,450,720
IPO [Member]
Temporary Equity [Line Items]
Gross proceeds					309,450,720
Less:
Proceeds allocated to Public Warrants					$ (10,211,874)

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of Basic and Diluted Income (Loss) Per Ordinary Share (Detail) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator:
Allocation of net income ( loss), as adjusted	$ 2,768,684	$ 2,830,646	$ (649,446)	$ (1,403,996)	$ 5,599,330	$ (2,053,442)
Common Class A [Member]
Numerator:
Allocation of net income ( loss), as adjusted		$ 2,214,947	$ (519,557)		$ 4,479,464	$ (1,488,651)
Denominator:
Basic weighted average ordinary shares outstanding	30,945,072		30,945,072		30,945,072	20,174,135
Diluted weighted average ordinary shares outstanding	30,945,072		30,945,072		30,945,072	20,174,135
Basic net income (loss) per share	$ 0.07		$ (0.02)		$ 0.14	$ (0.07)
Diluted net income (loss) per share	$ 0.07		$ (0.02)		$ 0.14	$ (0.07)
Common Class B [Member]
Numerator:
Allocation of net income ( loss), as adjusted	$ 553,737		$ (129,889)		$ 1,119,866	$ (564,791)
Denominator:
Basic weighted average ordinary shares outstanding	7,736,268		7,736,268		7,736,268	7,654,031
Diluted weighted average ordinary shares outstanding	7,736,268		7,736,268		7,736,268	7,654,031
Basic net income (loss) per share	$ 0.07		$ (0.02)		$ 0.14	$ (0.07)
Diluted net income (loss) per share	$ 0.07		$ (0.02)		$ 0.14	$ (0.07)

Public Offering - Additional In

Public Offering - Additional Information (Detail) - USD ($)			6 Months Ended		12 Months Ended
	Mar. 05, 2021	Mar. 04, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Public Offering [Line Items]
Stock issued during period value new issues		$ 300,000,000
Proceeds from sale of Private Placement Warrants			$ 0	$ 9,189,015
Payment to acquire restricted investments			9,450,720
Assets held in the trust account			$ 309,450,720
IPO [Member]
Public Offering [Line Items]
Proceeds from sale of Private Placement Warrants					$ 10,211,874
Over-Allotment Option [Member]
Public Offering [Line Items]
Stock issued during period shares new issues	945,072		4,500,000
Over-Allotment Option [Member] | Partial Exercise of Over Allotment Option [Member] | Underwriters [Member]
Public Offering [Line Items]
Stock issued during period shares new issues	945,072
Stock issued during period value new issues	$ 9,450,720
Class of warrant or rights issued during period	126,010
Class of warrant or rights issued during period, price per warrant or right	$ 1.5
Proceeds from sale of Private Placement Warrants	$ 189,015
Common Class A [Member] | Public Warrants [Member]
Public Offering [Line Items]
Common stock, conversion basis		Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 9).
Common Class A [Member] | IPO [Member]
Public Offering [Line Items]
Stock issued during period shares new issues		30,000,000
Shares issue price		$ 10
Warrants exercise price per share		$ 11.5
Common Class A [Member] | Over-Allotment Option [Member]
Public Offering [Line Items]
Stock issued during period shares new issues	945,072	30,000,000
Shares issue price		$ 10
Stock issued during period value new issues	$ 9,450,720

Private Placement - Additional

Private Placement - Additional Information (Detail) - USD ($)		6 Months Ended		12 Months Ended
	Mar. 05, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Proceeds from issuance of warrants		$ 0	$ 9,189,015
Private Placement Warrants [Member]
Class of warrants or rights, number of securities called by each warrant or rights		1
Class of warrants or rights, exercise price		$ 11.5
IPO [Member]
Proceeds from issuance of warrants				$ 10,211,874
IPO [Member] | Sponsor [Member] | Private Placement Warrants [Member]
Class of warrant or rights issued during period		6,000,000
Class of warrant or rights issued during period, price per warrant or right		$ 1.5
Proceeds from issuance of warrants		$ 9,000,000
Over-Allotment Option [Member] | Sponsor [Member] | Private Placement Warrants [Member]
Class of warrant or rights issued during period	126,010
Class of warrants or rights subscribed but not issued		600,000
Class of warrants or rights subscribed but not issued value		$ 900,000
Proceeds from derivative instrument, financing activities	$ 189,015

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)				1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 25, 2022	Apr. 15, 2021	Mar. 01, 2021	Dec. 31, 2020	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 29, 2020
Related Party Transaction [Line Items]
Common Stock Per Share Value					$ 10		$ 10
Sponsor [Member]
Related Party Transaction [Line Items]
Share price					$ 12		$ 12
Notice period to redeem shares							150 days
Sponsor [Member] | Working Capital Loan [Member]
Related Party Transaction [Line Items]
Due to related parties current					$ 0		$ 0		$ 0
Debt instrument convertible into warrants					$ 1,500,000		$ 1,500,000
Debt instrument conversion price					$ 1.5		$ 1.5
Sponsor [Member] | Promissory Note [Member]
Related Party Transaction [Line Items]
Debt instrument, face amount										$ 300,000
Due to related parties current										$ 171,357
Sponsor [Member] | Administrative Service Agreement [Member]
Related Party Transaction [Line Items]
Related party transaction, amounts of transaction							$ 10,000
Related party transaction. administrative expense					$ 30,000	$ 30,000	60,000	$ 40,000
Sponsor [Member] | Administrative Service Agreement [Member] | Accrued Liabilities [Member]
Related Party Transaction [Line Items]
Related party transaction. administrative expense							$ 160,000		$ 100,000
Sponsor [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Share transfer restriction, threshold trading days							30 days
Sponsor [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Number of consecutive trading days for share price determination							20 days
Class B ordinary shares
Related Party Transaction [Line Items]
Common stock shares outstanding				8,625,000	7,736,268		7,736,268		7,736,268
Common Stock Per Share Value					$ 0.0001		$ 0.0001		$ 0.0001
Class B ordinary shares | Founder Shares [Member] | Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period, value, issued for services				$ 25,000
Stock issued during period, shares, issued for services				7,187,500
Stock issued during period			1,437,500
Ordinary shares subject to possible redemption					1,125,000		1,125,000
Percentage of shares issued and outstanding					20%		20%
Shares issued, shares, share-based payment arrangement, forfeited		888,732
Class A ordinary shares
Related Party Transaction [Line Items]
Common stock shares outstanding					0		0		0
Ordinary shares subject to possible redemption					30,945,072		30,945,072		30,945,072
Common Stock Per Share Value					$ 0.0001		$ 0.0001		$ 0.0001
Class A ordinary shares | Sponsor Agreement [Member]
Related Party Transaction [Line Items]
Sponsor Agreement Lock In Period Of Shares	180 days
Common Stock Per Share Value	$ 12.5
Class A ordinary shares | Maximum [Member] | Sponsor Agreement [Member]
Related Party Transaction [Line Items]
Number of trading days determining closing price of Common shares	30 days
Class A ordinary shares | Minimum [Member] | Sponsor Agreement [Member]
Related Party Transaction [Line Items]
Number of trading days determining closing price of Common shares	20 days

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)			6 Months Ended
	Jul. 25, 2022	Mar. 05, 2021	Jun. 30, 2022	Jan. 27, 2021
Number of days after the completion of the business combination			30 days
Deferred underwriting fee payable, per unit			$ 0.35
Deferred underwriting fee payable			$ 10,830,775
Stock repurchased and retired during period, shares		3,554,928
Common stock par value			$ 10
Minimum [Member]
Number of trading days determining closing price of earnout shares			20 days
Maximum [Member]
Number of trading days determining closing price of earnout shares			30 days
Consulting Agreement [Member]
Consultant Fee	$ 2,000,000			$ 2,000,000
Merger Agreement [Member] | DHC Class A Ordinary Shares [Member]
Common stock par value			$ 0.0001
Common stock shares issued			40,000,000
Merger Agreement [Member] | DHC Class A Ordinary Shares [Member] | Minimum [Member]
Number of trading days determining closing price of earnout shares			20 days
Merger Agreement [Member] | DHC Class A Ordinary Shares [Member] | Maximum [Member]
Number of trading days determining closing price of earnout shares			30 days
Merger Agreement [Member] | DHC Class B Ordinary Shares [Member]
Common stock par value			$ 0.0001
Merger Agreement [Member] | DHC Class A Common Stock [Member]
Common stock par value			$ 0.0001
Sponsor Agreement [Member] | DHC Class A Common Stock [Member]
Common stock par value	$ 12.5
Sponsor Agreement Lock In Period Of Shares	180 days
Sponsor Agreement [Member] | DHC Class A Common Stock [Member] | Minimum [Member]
Number of trading days determining closing price of Common shares	20 days
Sponsor Agreement [Member] | DHC Class A Common Stock [Member] | Maximum [Member]
Number of trading days determining closing price of Common shares	30 days
Over-Allotment Option [Member]
Option vesting period			45 days
Stock issued during period		945,072	4,500,000

Shareholders' Deficit - Additi

Shareholders' Deficit - Additional Information (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common stock par value	$ 10
Common Stock [Member]
Class of Stock [Line Items]
Percentage of sum of ordinary shares issued and outstanding	20%
Common Class A [Member]
Class of Stock [Line Items]
Common stock shares authorized	500,000,000	500,000,000
Common stock par value	$ 0.0001	$ 0.0001
Common stock, voting rights	one
Common stock shares issued	0	0
Common stock shares outstanding	0	0
Temporary equity shares outstanding	30,945,072	30,945,072
Common Class B [Member]
Class of Stock [Line Items]
Common stock shares authorized	50,000,000	50,000,000
Common stock par value	$ 0.0001	$ 0.0001
Common stock, voting rights	one
Common stock shares issued	7,736,268	7,736,268
Common stock shares outstanding	7,736,268	7,736,268	8,625,000
Common stock, conversion basis	one-for-one basis

Warrant Liabilities - Additiona

Warrant Liabilities - Additional Information (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Number of days after consummation of business combination within which registration shall be made with securities exchange commission	20 days
Number of days after consummation of business combination within which registration with securities exchange commission shall be effective	60 days
Common Class A [Member]
Common stock shares lock in period	30 days
Common Class A [Member] | Event Triggering Adjustment To Exercise Price Of Warrants [Member]
Proceeds to be used for business combination as a percentage of total equity proceeds	60%
Sale of stock issue price per share	$ 9.2
Number of trading days for determining volume weighted average trading price of the ordinary shares	20 days
Volume Weighted Average Trading Price Of Shares	$ 9.2
Common Class A [Member] | Event Triggering Adjustment To Exercise Price Of Warrants [Member] | Warrant Exercise Price One [Member]
Class of warrants or rights, Exercise price as a percentage of newly issued price	115%
Common Class A [Member] | Event Triggering Adjustment To Exercise Price Of Warrants [Member] | Warrant Exercise Price Two [Member]
Class of warrants or rights, Exercise price as a percentage of newly issued price	180%
Share Price $10 [Member] | Common Class A [Member] | Share Redemption Triger Price [Member]
Share price	$ 10
Public Warrants [Member]
Class of warrants or rights, outstanding	10,315,024	10,315,024
Class of warrants or rights period after which the warrants or rights are exercisable	1 year
Class of warrant or right days from which warrants or rights exercisable	30 days
Warrants or rights outstanding, term	5 years
Public Warrants [Member] | Common Class A [Member] | Redemption Trigger Price One [Member]
Share price	$ 18
Class of warrants or rights, redemption price per warrant or right	$ 0.01
Class of warrants or rights, notice of redemption period	30 days
Number of trading days determining closing price of ordinary shares	20 days
Number of consecutive trading days for determining the closing price of shares	30 days
Period during which the registered propsectus shall be available for warrant redemption	30 days
Public Warrants [Member] | Common Class A [Member] | Redemption Trigger Price Two [Member]
Share price	$ 10
Class of warrants or rights, redemption price per warrant or right	$ 0.1
Class of warrants or rights, notice of redemption period	30 days
Number of consecutive trading days for determining the closing price of shares	30 days
Private Placement Warrants [Member]
Class of warrants or rights, outstanding	6,126,010	6,126,010
Class of warrants or rights lock in period	30 days
Private Placement Warrants [Member] | Common Class A [Member]
Share price	$ 18
Number of trading days determining closing price of ordinary shares	20 days
Number of consecutive trading days for determining the closing price of shares	30 days

Fair Value Measurements - Summa

Fair Value Measurements - Summary Company's Liabilities that are Measured at Fair Value on a Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Level 1 [Member]
Assets:
Investment held in Trust Account	$ 309,898,790.83
Public Warrants [Member] | Level 1 [Member] | Warrant [Member]
Liabilities:
Warrant Liability	754,028	$ 5,207,024
Private Placement Warrants [Member] | Level 2 [Member] | Warrant [Member]
Liabilities:
Warrant Liability	$ 447,811	$ 3,092,410

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Change in the Fair Value of Warrant Liabilities (Detail) - Warrant [Member] - USD ($)	3 Months Ended
	Jun. 30, 2021	Mar. 31, 2021
Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value	$ 6,309,790	$ 0
Change in fair value	0	245,040
Transfer to Level 2	0
Fair value	6,309,790	6,309,790
Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value	10,624,475	0
Change in fair value	(103,151)	412,621
Transfer to Level 2	(10,521,324)
Fair value	0	10,624,475
Warrant Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value	16,934,265	0
Change in fair value	(103,151)	657,641
Transfer to Level 2	(10,521,324)
Fair value	$ 6,309,790	16,934,265
IPO [Member] | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement		5,940,000
IPO [Member] | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement		9,900,000
IPO [Member] | Warrant Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement		15,840,000
Over-Allotment Option [Member] | Private Placement Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement		124,750
Over-Allotment Option [Member] | Public Warrants [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement		311,874
Over-Allotment Option [Member] | Warrant Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Initial measurement		$ 436,624

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2021	Jun. 30, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets held in the trust account			$ 309,898,791	$ 309,450,720
Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3	$ 0	$ 0
Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3		$ 10,521,324

Subsequent Events - Addtional I

Subsequent Events - Addtional Information (Detail) - USD ($) $ / shares in Units, shares in Millions		6 Months Ended
	Jul. 25, 2022	Jun. 30, 2022	Jan. 27, 2021
Subsequent Event [Line Items]
Class A common stock, per shares		$ 10
Subsequent Event [Member]
Subsequent Event [Line Items]
Payments for legal settlements	$ 500,000
Maximum [Member]
Subsequent Event [Line Items]
Number of trading days determining closing price of earnout shares		30 days
Minimum [Member]
Subsequent Event [Line Items]
Number of trading days determining closing price of earnout shares		20 days
Merger Agreement [Member] | DHC Class A Ordinary Shares [Member]
Subsequent Event [Line Items]
Class A common stock, per shares		$ 0.0001
Common stock, shares, issued		40
Merger Agreement [Member] | DHC Class A Ordinary Shares [Member] | Maximum [Member]
Subsequent Event [Line Items]
Number of trading days determining closing price of earnout shares		30 days
Merger Agreement [Member] | DHC Class A Ordinary Shares [Member] | Minimum [Member]
Subsequent Event [Line Items]
Number of trading days determining closing price of earnout shares		20 days
Merger Agreement [Member] | DHC Class B Ordinary Shares [Member]
Subsequent Event [Line Items]
Class A common stock, per shares		$ 0.0001
Merger Agreement [Member] | DHC Class A Common Stock [Member]
Subsequent Event [Line Items]
Class A common stock, per shares		$ 0.0001
Sponsor Agreement [Member] | DHC Class A Common Stock [Member]
Subsequent Event [Line Items]
Class A common stock, per shares	$ 12.5
Sponsor agreement lock in period of shares	180 days
Sponsor Agreement [Member] | DHC Class A Common Stock [Member] | Maximum [Member]
Subsequent Event [Line Items]
Number of trading days determining closing price of Common shares	30 days
Sponsor Agreement [Member] | DHC Class A Common Stock [Member] | Minimum [Member]
Subsequent Event [Line Items]
Number of trading days determining closing price of Common shares	20 days
Consulting Agreement [Member]
Subsequent Event [Line Items]
Consultant Fee	$ 2,000,000		$ 2,000,000